Schizophrenia Research and Treatment / 2013 / Article / Tab 1

Clinical Study

Cognitive Training for Schizophrenia in Developing Countries: A Pilot Trial in Brazil

Table 1

Demographic and clinical characteristics at baseline and treatment attendance.

Experimental Control

Institution (% SPU)66.7751.000°
Gender (male %)89750.576°
Age (mean ± SE) 0.735*
Duration of illness (mean ± SE) 0.885*
Number of previous hospitalizations
(mean ± SE)
Years of education (mean ± SE) 1.000*
I.Q. (mean ± SE) 0.961*
PANSS negative subscale (mean ± SE) 0.697*
PANSS positive subscale (mean ± SE) 0.699*
PANSS general psychopathology subscale (mean ± SE) 0.409*
PANSS total (mean ± SE) 0.735*
Trail making test A (mean ± SE) 0.630*
Trail making test B (mean ± SE) 0.564*
Stroop test card I (mean ± SE) 0.772*
Stroop test card II (mean ± SE) 0.359*
Stroop test card III (mean ± SE) 0.441*
MWCST total categories (mean ± SE) 0.883*
MWCST perseverative errors (mean ± SE) 1.000*
MWCST failure to maintain set (mean ± SE) 0.406*
Logic memory I (mean ± SE) 0.847*
Logic memory II (mean ± SE) 0.286*
Visual reproduction I (mean ± SE) 0.225*
Visual reproduction II (mean ± SE) 0.016 *
Treatment attendance (mean ± SE) 0.481*

SE: standard error, °Fisher's exact test, and *Mann-Whitney test for independent samples.
SPU: Schizophrenia Project Unit at the Institute of Psychiatry of University of São Paulo (USP) Medical School.
PANSS: positive and negative syndrome scale for schizophrenia, MWCST: modified Wisconsin card sorting test.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.